Neutrophil-to-lymphocyte ratio as a predictor of left ventricle function and mortality in patients with myocardial

Michał Węgiel1, Kinga Glądys2, Barbara Zdzierak1,3

  • 1Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland.

Insights

The neutrophil-to-lymphocyte ratio (NLR) can predict poor outcomes after myocardial infarction (MI). Elevated NLR indicates worse left ventricular function and higher mortality risk in MI patients, aiding long-term risk stratification.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Outcomes

Background:

  • Myocardial infarction (MI) significantly impacts long-term patient outcomes, including remodeling, heart failure, and mortality.
  • Optimal biomarkers for risk stratification in MI patients remain debated, highlighting a need for improved predictive tools.

Purpose of the Study:

  • To evaluate the neutrophil-to-lymphocyte ratio (NLR) as a potential biomarker.
  • To assess the association between NLR and long-term clinical and echocardiographic outcomes following MI.

Main Methods:

  • Analysis of 412 patients hospitalized for MI between 2016-2019.
  • Collection of demographic, clinical, biochemical, angiographic, and echocardiographic data.
  • Long-term clinical and echocardiographic follow-up of patients.

Main Results:

  • NLR showed a negative correlation with baseline and follow-up left ventricular ejection fraction (LVEF).
  • Elevated NLR predicted long-term reduced LVEF and all-cause mortality.
  • NLR > 8.7 was associated with significantly poorer survival rates.

Conclusions:

  • Elevated NLR is linked to impaired left ventricular function post-MI.
  • NLR serves as a significant predictor of increased mortality in patients after myocardial infarction.
Abstract